Universitäts-Herzzentrum Freiburg - Bad Krozingen GmbH

Hospital


Location: Freiburg / Bad Krozingen, Germany (DE) DE

ISNI: 0000000404932307

ROR: https://ror.org/02w6m7e50

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Response to letter regarding article, "ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension" (2014) Mahfoud F, Ukena C, Schmieder R, Cremers B, Rump LC, Vonend O, Weil J, et al. Journal article Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): A randomised, open-label trial (2013) Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, Tiroch K, Schulz S, et al. Journal article One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: Updated results from the ISAR-REACT 4 trial (2013) Schulz S, Kastrati A, Ferenc M, Massberg S, Birkmeier KA, Laugwitz KL, Kufner S, et al. Journal article Prognostic value of access and non-access sites bleeding after percutaneous coronary intervention (2013) Ndrepepa G, Neumann FJ, Richardt G, Schulz S, Toelg R, Stoyanov KM, Gick M, et al. Journal article Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy (2013) Ndrepepa G, Schulz S, Neumann FJ, Byrne RA, Hoppmann P, Cassese S, Ott I, et al. Journal article Recommendations of the project group prevention of the German Cardiac Society (DGK) on risk adjusted prevention of cardiovascular diseases: Part 3: Dyslipidemia, arterial hypertension and glucose metabolism Empfehlungen der Projektgruppe Prävention der DGK zur risikoadjustierten Prävention von Herz- und Kreislauferkrankungen: Teil 3: Fettstoffwechselstörungen, arterielle Hypertonie und Glukosestoffwechsel (2013) Gohlke H, Albus C, Bönner G, Darius H, Eckert S, Gohlke-Bärwolf C, Gysan D, et al. Journal article
‹ 1 ... 8 9 10 ›